Regimbeau has been ranked among the top French firms in pharmaceutical patents, according to a recent study undertaken by Patent-Pilot. A great performance for Regimbeau, especially since most of the patent applications in question are drafted by our teams, as part of the daily support of our direct clients, whom we thank for their trust.
On the same topic
WTR 1000 – 2026 Ranking
We are pleased to announce that Regimbeau has once again been recognised in the World Trademark Review WTR 1000 ranking – France, achieving a Silver ranking, confirming its longstanding position as a key player in the intellectual property landscape. This distinction highlights the firm’s unwavering commitment to brand protection and its strategic expertise in preserving brand value across Europe. According to...
ByIP Stars 2025 : New distinctions for Regimbeau and its experts
We are pleased to announce that four of our experts have been distinguished in the IP Stars 2025 ranking. As a reminder, IP Stars is a globally recognized ranking of...
ByRegimbeau recognized among Europe’s Leading Patent Law Firms in the Financial Times Ranking – 2025 Edition
We are honored to announce that Regimbeau has once again been recognized in the Financial Times’ 2025 edition of Europe’s Leading Patent Law Firms. This prestigious annual ranking, compiled in...